Skip to main content
PHAT logo

PHAT · Phathom Pharmaceuticals, Inc.

$11.64 -0.02 (-0.17%) At close · Jul 29 Earnings today
Market Cap
$928.36M
Shares
79.76M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Steven L. Basta $6,968,070
Terrie Curran $4,936,791
Sanjeev Narula $3,617,962
Azmi Nabulsi $2,714,314
Anne Marie Cook $2,100,002
Fiscal 2024
Executive Total
Terrie Curran $3,564,883
Azmi Nabulsi $1,566,541
Molly Henderson $1,424,212
Fiscal 2023
Executive Total
Terrie Curran $3,411,022
Azmi Nabulsi $2,035,913
Molly Henderson $1,873,793
Fiscal 2022
Executive Total
Terrie Curran $5,039,878
Azmi Nabulsi $2,762,453
Molly Henderson $2,648,537
Fiscal 2021
Executive Total
Terrie Curran $6,272,655
Azmi Nabulsi $4,321,236
Anthony Guzzo $1,365,153
Fiscal 2020
Executive Total
Terrie Curran $4,634,454
Azmi Nabulsi $2,364,214
Todd P. Branning $2,047,404
Fiscal 2019
Executive Total
Terrie Curran $3,459,096
David Socks $542,127
Azmi Nabulsi $531,029
Aditya Kohli $280,820
Key facts CIK 1783183 CUSIP 71722W107 13F (30d) 22 filings 22 filers Visit website Investor relations